Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pediatric vaccine stockpile policies need to be revisited, researcher says

10.09.2010
Vaccine manufacturers and public health decision-makers need to collaborate in a more efficient and effective manner not only to reduce the likelihood of supply shortages for pediatric vaccines but also to maximize community immunity by using vaccine doses to increase coverage, according to research published by a University of Illinois researcher who specializes in statistics and data analysis.

Sheldon H. Jacobson, a professor of computer science and the director of the simulation and optimization laboratory at Illinois, says that the Pediatric Vaccine Stockpile Program administered by the Centers for Disease Control and Prevention should not simply be seen as a repository of vaccines, but rather as a "repository of opportunities" for enhancing the collective immunity of children.

"We hear a lot about bioterrorism and pandemics, but the fact of the matter is, the threat to routine immunization is one of the greatest threats we face," Jacobson said. "If we had problems with our vaccine supply chain, it would have the potential to cause more deaths than any of those other issues."

With an average of 11,000 children in need of immunization on any given day, Jacobson says that managing pediatric vaccine stockpiles shouldn't simply be limited to increasing the levels of the stockpile itself.

"Just like perishable goods, vaccines have a shelf life," Jacobson said. "They're not like canned goods that you can simply stockpile and forget about for an extended period of time.

"When you have finite economic resources, you have to make choices. But we also want to create a buffer that will create the widest possible public health safety net."

The CDC's current policy of maintaining a six-month rotating vaccine stockpile isn't the most optimal solution for achieving "herd immunity," which Jacobson defines as "the smallest percentage of a population that must be immunized against a disease so that unvaccinated individuals are also protected."

Jacobson, who published his research in the Journal of Industrial and Management Optimization, considered the relative mortality and morbidity of diseases to determine what levels stockpiles should be set at to minimize the risk of shortage and maximize coverage opportunities while minimizing costs.

"We took all of these factors into account and created a multi-attribute model using utility theory to solve for appropriate levels."

Jacobson said that when actual vaccine shortages have occurred over the last 10 years, the duration of the shortages were between 16 and 18 months.

"Even though we're preparing for six months out, we never see six months," he said. "The shortest time period in the last 10 years has been a 7-month period. That's a byproduct of one-size-fits-all policy for stockpiles. Although it's easy and simple to do, it's not the most efficient policy. We need to re-engineer the objectives of our pediatric vaccine stockpiles and establish more flexible policies for maximizing their utility."

Jacobson's research proposes a stochastic model to determine the stockpile levels that minimize the risk of a vaccine shortage during a supply interruption while also maintaining a given coverage rate.

"For some vaccines, you need very little stockpiles; for others, you need much larger ones," he said.

Pertussis, or whooping cough, as it's more commonly known, can be a "very deadly, virulent disease if it spreads, while mumps, on the other hand, rarely causes death," Jacobson said.

"When we're talking about vaccines, equal is not effective. The recent pertussis outbreaks in California and Ohio highlight the needs for differentiated stockpile levels, meaning we have to look at the characteristics of the diseases in terms of achieving herd immunity as well as how deadly the disease is."

Jacobson, who also is a professor of pediatrics at the College of Medicine on the Urbana campus, said that although routine immunization is the most effective public health strategy to prevent the occurrence and spread of infectious diseases, there's always going to be a certain small percentage of the population who will not be immunized, because of religious beliefs or allergies to the vaccine.

"The CDC's goal for immunization is 95 percent compliance," he said. "They don't expect 100 percent. But if you get to 95 percent, you're typically going to have a herd immunity."

Ultimately, vaccination is a critical public health issue that can't be run by the vagaries of emotion.

"If we allow our emotions to guide our policies, we'll pay the price somewhere down the line. The public health system saves rather than costs our nation money. And any way that we can reduce mortality and morbidity through immunization would be beneficial to the health-care system both in cost and value and to the nation as a whole."

Co-authors of the study were Dr. Janet A. Jokela, the head of medicine and of the internal medicine residency program for the U. of I. College of Medicine at Urbana-Champaign; and Ruben A. Proano, a professor of industrial and systems engineering at the Rochester Institute of Technology.

The National Science Foundation funded the project.

Phil Ciciora | EurekAlert!
Further information:
http://www.illinois.edu

More articles from Health and Medicine:

nachricht TSRI researchers develop new method to 'fingerprint' HIV
29.03.2017 | Scripps Research Institute

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>